ALS Finding a Cure
Overview
ALS Finding a Cure is a research-focused organization and a program of The Leandro P. Rizzuto Foundation. Its mission is to fund research to find a cure for Amyotrophic Lateral Sclerosis (ALS). The organization invests in and collaborates on projects related to new technologies, biomarkers, diagnostics, and clinical trials to address gaps in the scientific understanding of ALS. It was founded in 2014 by Leandro (Lee) Rizzuto.
Portfolio Companies
3
Website
alsfindingacure.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Amylyx Pharmaceuticals | Jul 2016 | Grant | Co-investor |
| Emulate, Inc. | Oct 2016 | Series B Extension | Lead |
| Revalesio | Sep 2017 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ALS Finding a Cure based?
ALS Finding a Cure is headquartered in United States.
When was ALS Finding a Cure founded?
Founding year information for ALS Finding a Cure is not publicly available.
How many portfolio companies does ALS Finding a Cure have?
ALS Finding a Cure has 3 portfolio companies in Caplight's dataset.
What are some companies in ALS Finding a Cure's portfolio?
Portfolio companies visible on Caplight include Amylyx Pharmaceuticals, Emulate, Inc., Revalesio.
What was ALS Finding a Cure's most recent investment shown here?
ALS Finding a Cure's most recent investment in this portfolio sample was in Revalesio in 2017.
What sectors does ALS Finding a Cure focus on?
ALS Finding a Cure focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does ALS Finding a Cure focus on?
Stage focus information for ALS Finding a Cure is not publicly available.
What is ALS Finding a Cure's AUM?
ALS Finding a Cure's assets under management are estimated between $31.0M and $31.0M.